Outpace Bio, Inc. — Form D

Outpace Bio, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-01. The offering totals $144.2M, of which $56.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2024-08-01
Form: D
Accession: 0002031531-24-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $144.2M
Amount sold: $56.0M
Remaining: $88.2M
Investors: 25
Date of first sale: 2024-07-17
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-520350

Issuer

Name: Outpace Bio, Inc.
CIK: 0002031531
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 700 Dexter Ave N, Suite 300, SEATTLE, WA, 98109
Phone: 206-422-1367

Officers, directors & promoters (12)

Name	Role	Location
Vasudev Bailey	Director	New Yoprk City, NY
Scott Boyken	Director	Seattle, WA
Bahija Jallal	Director	Seattle, WA
Marc Lajoie	Director	Seattle, WA
Jake Simson	Director	San Mateo, CA
Scott Boyken	Executive Officer	Seattle, WA
Aaron Foster	Executive Officer	Seattle, WA
Marc Lajoie	Executive Officer	Seattle, WA
Charity Scripture	Executive Officer	Seattle, WA
Eric Soller	Executive Officer	Seattle, WA
Scott Boyken	Promoter	Seattle, WA
Marc Lajoie	Promoter	Seattle, WA

More